Laith Alexander πŸ³οΈβ€πŸŒˆ (@Laithalexander) header
Laith Alexander πŸ³οΈβ€πŸŒˆ (@Laithalexander) profile picture

Academic Clinical Fellow @KingsIoPPN | Resident Doctor @MaudsleyNHS | Brain, emotion, mood disorders | Views my own

London, England
Joined April 2012
Photo by Laith Alexander πŸ³οΈβ€πŸŒˆ (@Laithalexander)Photo by Laith Alexander πŸ³οΈβ€πŸŒˆ (@Laithalexander)Photo by Laith Alexander πŸ³οΈβ€πŸŒˆ (@Laithalexander)Photo by Laith Alexander πŸ³οΈβ€πŸŒˆ (@Laithalexander)Photo by Laith Alexander πŸ³οΈβ€πŸŒˆ (@Laithalexander)Photo by Laith Alexander πŸ³οΈβ€πŸŒˆ (@Laithalexander)Photo by Laith Alexander πŸ³οΈβ€πŸŒˆ (@Laithalexander)Photo by Laith Alexander πŸ³οΈβ€πŸŒˆ (@Laithalexander)Photo by Laith Alexander πŸ³οΈβ€πŸŒˆ (@Laithalexander)Photo by Laith Alexander πŸ³οΈβ€πŸŒˆ (@Laithalexander)
Laith Alexander πŸ³οΈβ€πŸŒˆ retweeted
'Academic Psychiatry meets Clinical Psychiatry' 31/10/25 @rcpsych βœ…Juggling clinical work&&research @lynne_drummond βœ…Short&longterm directions in psych&neuro research βœ…Clinical work&Academia: What is left to do to bridge the gap?@Derektracy1 Book now lnkd.in/ecmkZzeT
2
8
23
2,118
Laith Alexander πŸ³οΈβ€πŸŒˆ retweeted
1/ Just out inβ€―@NatureMedicine : we show the opioid system modulates ketamine’s effects in major depressive disorder, with naltrexone pre‑treatment reducing acute glutamatergic activity and acute antidepressant effects. nature.com/articles/s41591-0…
6
44
5
107
17,721
Laith Alexander πŸ³οΈβ€πŸŒˆ retweeted
Most studies on esketamine (and the UK licence) have been as add-on to antidepressants. This study suggests monotherapy may also be effective - although only short term data. As ever the challenge with (es)ketamine comes in the longer term.
Esketamine nasal spray as a monotherapy improved depressive symptoms in treatment-resistant depression (TRD) compared to placebo. ja.ma/3ZYkZIv
2
8
24
2,779
Hot off the press!!! Prof Michael Browning from @UniofOxford presenting data from the PAX-D trial, looking a dopaminergic medication to augment the treatment of depression. #BAP2025
4
787
Prof Robinson describing the affective bias test, a translationally relevant assay to explore the effects of affective state on memory bias #BAP2025
1
730
Next up - Prof Emma Robinson, speaking about her exciting research developing preclinical models of psychiatric symptoms #BAP2025
1
626
The Head Twitch Response is not the perfect model of psychedelic experiences in mice #BAP2025
1
554
It is #BAP2025 and we are at the first symposium of the day! Starting with Dr Thomas Blackmore and preclinical models of psychedelic efficacy. Exciting.
4
784
Laith Alexander πŸ³οΈβ€πŸŒˆ retweeted
Our new @NIHRMaudsleyBRC CRIS study shows that bipolar disorder is associated with a lower risk of dementia than depression | The British Journal of Psychiatry | Cambridge Core - bit.ly/3XH48sy
5
3
1,706
Paper out in @TheBJPsych exploring link between late-life depression vs. anxiety vs. bipolar disorder and dementia. Compared to depression, anx had same risk but bipolar was lower. We found several demographic & clinical factors influencing risk too. bit.ly/3XH48sy
3
11
2
40
4,813
Absolutely delighted that I’ve finally passed CASC. So happy that ordeal is over, particularly after the run in with Guillain Barre.
14
135
9,415
Laith Alexander πŸ³οΈβ€πŸŒˆ retweeted
Anatomy of Moncrieff's Anti-Medication Playbook @joannamoncrieff has a carefully honed 3-step strategy of attacking psychiatry, which she has used with remarkable power against the medical establishment. Step 1: Identify a narrow, technical assertion pertaining to the neurobiology or medical treatment of mental health problems, and show that the evidence supporting that assertion is not as strong or high quality as commonly believed. Step 2: Use the uncertainty of evidence to make the claim, or imply, or pretend that the assertion has been shown to be false. [This step is a logically invalid inference since weak evidence in favor of thesis A does not equal strong evidence in favor of inverse A.] Step 3: Use the claim as a stepping stone to bash medical psychiatry by making claims that extend far beyond the scope of the narrow, technical assertion in step 1. Rely on rhetoric, ignorance of the audience, and prevalent prejudices to pull this off, and make strategic motte-and-bailey retreats when needed. This 3-step attack is bolstered by 2 ancillary moves: a) Make isolated demands for rigor, and set the required bar of evidence to a level that favors one’s own position, while simultaneously lowering the bar or shifting the burden of proof when it suits your favored positions. b) Pretend your personal opinion carries the same epistemic weight as the clinical consensus of the medical community. See details of how this play out in my post: psychiatrymargins.com/p/anat…
43
51
20
184
73,883
Laith Alexander πŸ³οΈβ€πŸŒˆ retweeted
Please see Division vacancies for this week. If you are interested in any of the positions listed below, please get in touch. Feel free to share this information with anyone who might be interested.
2
2
1,378
Laith Alexander πŸ³οΈβ€πŸŒˆ retweeted
❔ What are the early career psychiatrists' perceptions of and training experience in electroconvulsive therapy? πŸ“‹ A cross-sectional survey across Europe has been published in European Psychiatry! πŸ”— Open access: doi.org/10.1192/j.eurpsy.202…
4
1
15
1,708
Our survey exploring early career psychiatrists’ perceptions of ECT is out @Euro_Psychiatry bit.ly/3DRPjfv - Across Europe, perception favourable - Willingness for more training Wonderfully led by @CTapoi & Dr Pinto da Costa @KingsIoPPN
1
6
2
27
3,661
Laith Alexander πŸ³οΈβ€πŸŒˆ retweeted
Would you like to make a difference and be part of what happens in your region? The London Division have some fantastic opportunities to get involved. Apply today to become part of the Executive Committee. rcpsych.ac.uk/members/englan…
3
4
1,602